Skip to main content
Clinical Trials/CTRI/2019/01/017283
CTRI/2019/01/017283
Not yet recruiting
未知

A randomized study to determine the Sun Protection Factor of PteroWhite® in female subjects.

Sami Labs Limited0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Sami Labs Limited
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Sami Labs Limited

Eligibility Criteria

Inclusion Criteria

  • 1 Subjects in age group 18â??55 years both inclusive.
  • 2 Subjects with Fitzpatrick skin type III and IV.
  • 3 Subjects willing to discontinue the use of soaps and cosmetic products (e.g. creams, moisturizers)in the treatment areas throughout the course of the study.
  • 4 Subjects willing to avoid any exposure of the test area to artificial or natural ultraviolet (UV) light throughout the course of the study.
  • 5 Subjects willing to give a voluntary written informed consent.
  • 6 Subject having not participated in a similar investigation in the past two weeks.
  • 7 Subjects willing to come for regular follow up visits.
  • 8 Subjects ready to follow instructions during the study period.
  • 9 Subjects with no known abnormal response to sunlight.

Exclusion Criteria

  • 1 Subjects allergic to cosmetic products such as moisturizers, creams and body lotion.
  • 2 Infection, allergy on the tested area.
  • 3 Skin allergy antecedents or atopic subjects.
  • 4 Subjects having history of or having active photo dermatitis.
  • 5 Subjects with cutaneous disease which may influence the study result.
  • 6 Subjects on oral corticosteroid.
  • 7 Subjects participating in any other cosmetic or therapeutic study.
  • 8 Subjects who are pregnant or lactating
  • 9 Subjects with sunburn or sun tan (in the tested area).
  • 10 Subjects with any history of underlying uncontrolled medical illness including diabetes, liver disease or history of alcoholism, HIV or any other serious medical illness.

Outcomes

Primary Outcomes

Not specified

Similar Trials